https://www.selleckchem.com/products/plx51107.html
12-2.06; p = .006), but not the presence of hypoglycaemia, were additively and independently associated with an increased risk of mortality. An MG 140 mg/dL with a CV 0.29 increased the mortality rates (123 vs. 317 per 1000 patient-year; p .001) and the adjusted mortality risk (HR = 2.70; 95% CI 1.71-4.27; p .001) compared with having an MBG ≤ 140 mg/dL. The simultaneous presence of a high MBG level and CV constitutes a powerful tool for stratifying mortality risk after hospital discharge. The simultaneous presence
Like
Comment
Share
